Lithuanian life sciences production is exported to over then 100 countries, 16 research centres cooperate with both domestic and foreign biotechnology companies and universities. Current spotlight of research pointed on bioinformatics.
Labor productivity in pharmaceuticals sector is almost 5 times higher than the overall economy‘s labor productivity.
Ground breaking results in the fields of:
Pharmaceuticals protein
Chemistry
Biochemistry of enzymes and nucleic acids
Molecular biology of prokaryote and eukaryote
Clinical Trials
Clinical trials in Lithuania cover a range of therapeutic areas, such as: Endocrilogy, Gastroenterlogy, Rheumatology, Pulmonology, Infectology, Dermatology, Urology, Pediatric, Surgery, Nephrology, Cardiology, Psychiatry, Hematology, Neurology, Oncology, Ophthalmology. There are more than 1200 clinical trials ongoing in the country. Over 90 International pharma and medical companies are conducting clinical trials in Lithuania.
R&D
There are 8300 R&D researchers and scientists in various fields. Expenditures for R&D doubled since the financial crisis. There are favorable tax incentives for investments into R&D, including:
Triple deduction: expenses incurred by companies while carrying out R&D can be deducted from taxable income tree times;
Super-accelerated depreciation: the acquisition price of fixed assets used int the R&D activities can be written-off within two years;
Investments into substantial technology improvements: entitle companies to reduce taxable profits by 50%.
Medical devices
Medical Devices export (incl. re-export) more than doubled since 2008. Main export markets: United Kingdom, France, Russia, Spain, USA. Research areas include biomedical diagnostics and monitoring systems, efficiency research of electronic security systems, analysis and synthesis of electronical devices, quality of electronic systems. Industrial electronics, including medical and defense electronics has been a prevalent application sector in electronics manufacturing with telecommunication equipment.
Lasers
Lithuania, with 10% of the global market, is one of the main exporters of femtosecond lasers systems in the world, a 80% of total Lithuanian laser production exported to nearly 100 countries (key markets: Germany, USA, Japan). Continuous industry growth reach 20% per year. Clients and partners of Lithuanian laser manufacturers include: NASA the nuclear Research centre in Israel, Rutherford Laboratories in England, Berkeley University in the USA, The Livermore National Laboratory, etc. It took 80% of the global production of ultra-fast parametric amplifiers. Laser manufacturing sector of Lithuania shows a 15-20% growth per year. Every 10th scientific laser used in the world is produced in Lithuania.
Talent pool
Lithuanian education is in the 1st place in EU for share of graduates in total population, in CEE – for quality of math and science education. 11 % of all students are enrolled in programmes related to life sciences.
Lithuania: new destination where life sciences trend-setters meet
Every two years Enterprise Lithuania is organizing Life Sciences Baltics which is the only international forum in the Baltics and Nordic region for world-class biotechnology, pharmaceutical and medical devices experts from all around the world. Enterprise Lithuania is the main organizer and driver of this biannual science and business forum.
We inform you about cookies on this site. By agreeing, click on the "I Agree" button or navigate further. You can cancel your consent at any time by changing your Internet browser settings and deleting saved cookies.I AGREEMORE
